It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Alzheimer's diagnosis revamp embraces rating scale similar to cancer

World / Science & Health Jul 17, 2023

Alzheimer's diagnosis revamp embraces rating scale similar to cancer

by Julie Steenhuysen

New guidelines would replace terminology such as mild, moderate and severe, instead using a numerical system related to disease progression.

The meds they bought were toxic. Now Gambian parents seek justice.

World / Crime & Legal Jul 15, 2023

The meds they bought were toxic. Now Gambian parents seek justice.

by Edward Mcallister

Filing a lawsuit against the Gambian government is a rare step in one of Africa's poorest countries, where few have the means to challenge authorities.

First over-the-counter birth control pill approved by U.S. regulators

World / Science & Health Jul 13, 2023

First over-the-counter birth control pill approved by U.S. regulators

The decision widens access to the drug by removing substantial barriers to obtaining oral contraception, such as inability to get a doctor’s appointment.

Challenges persist as scandals plague Japan’s generic drug push

National / Science & Health | FOCUS Jul 12, 2023

Challenges persist as scandals plague Japan’s generic drug push

by Kathleen Benoza

The aftermath of a series of manufacturing scandals is leading to shortages of the more affordable alternatives to brand-name medicine.

Eisai appoints CEO’s son to lead global Alzheimer drug program

Business / Corporate Jul 11, 2023

Eisai appoints CEO’s son to lead global Alzheimer drug program

by Kanoko Matsuyama

Eisai's former global Alzheimer drug program officer, who led the push for U.S. approval of breakthrough medicine Leqembi, will retire at the end of the month.

Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy

World / Science & Health Jul 7, 2023

Eisai Alzheimer's drug gets full U.S. approval, widening access to the therapy

by Robert Langreth

The broader clearance from the Food and Drug Administration marks a milestone for treatment of the dementia that afflicts some 6 million Americans.

South Korean doctors flee pediatrics as low birth rate makes funding unviable

Asia Pacific / Social Issues Jul 6, 2023

South Korean doctors flee pediatrics as low birth rate makes funding unviable

by Joyce Lee and Ju-min Park

Fewer children combined with a failure of the insurance system to adapt to the situation has left the sector starved of resources, with specialists shunning a field they think has no future.

Expectations grow for Alzheimer's drug in Japan, but hurdles remain

National / Science & Health | FOCUS Jul 4, 2023

Expectations grow for Alzheimer's drug in Japan, but hurdles remain

by Tomoko Otake

Lecanemab could be approved in the country as early as fall, but more specialist doctors and a patient screening system would be needed for widespread use.

Return of tourists drives shift in Japan's top-selling goods in 2023

Business Jul 4, 2023

Return of tourists drives shift in Japan's top-selling goods in 2023

by Yukana Inoue

Increased sales of cosmetics and certain health goods, combined with declines for pandemic-related products, highlight the return of tourists and Japan's shift toward a post-COVID era.

Can we cure dementia before it starts?

Commentary / World Jul 3, 2023

Can we cure dementia before it starts?

by F.D. Flam

Octogenarian and biologist Leroy Hood is trying to make the Elizabeth Holmes-ian dream of preventive medicine come true.

Eli Lilly’s new weight-loss drug is even better than Ozempic

Commentary / World Jun 28, 2023

Eli Lilly’s new weight-loss drug is even better than Ozempic

by Lisa Jarvis

When it comes to manipulating the human metabolism, we’re entering entirely new territory with new drugs.

Japan to launch prescription-free trial sale of morning-after pill

National / Science & Health Jun 27, 2023

Japan to launch prescription-free trial sale of morning-after pill

Under current rules, women, including victims of sexual assault, must go to a clinic or hospital for a prescription to obtain an emergency contraceptive.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times